225 results on '"Mount, Peter F."'
Search Results
2. Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial
3. Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin
4. Bone microarchitecture and estimated failure load are deteriorated whether patients with chronic kidney disease have normal bone mineral density, osteopenia or osteoporosis
5. Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation
6. Outcomes of patients commencing peritoneal dialysis with and without back-up arteriovenous fistulas
7. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
8. Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial
9. Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis
10. Tunnelled central venous catheters for incident haemodialysis patients – a Victorian survey exploring reasons for use
11. Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: a prospective observational cohort study
12. Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney
13. Glomerulonephritis
14. COVID‐19 beliefs and vaccination uptake in dialysis patients: lessons from an anonymous patient survey
15. Lower versus Higher Starting Tacrolimus Dosing in Kidney Transplant Recipients
16. Balancing the energy equation for healthy kidneys#
17. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
18. Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells
19. Effect of a medium cut‐off dialyzer on protein‐bound uremic toxins and mineral metabolism markers in patients on hemodialysis
20. Additional file 1 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
21. Additional file 6 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
22. Additional file 5 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
23. Additional file 2 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
24. Additional file 4 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
25. Additional file 3 of Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation
26. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation
27. Relationship between residual kidney function and symptom burden in haemodialysis patients
28. Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-[Ser.sup.1177]
29. Gastroenteritis
30. Gut Dysfunction
31. Glasgow Coma Scale
32. Gift-of-Life Management
33. Gustilo-Anderson Type IIIB or IIIC Open Fracture
34. Gastric Residual Volumes
35. Glucose Modulation
36. Gastrointestinal Hemorrhage
37. Glomerular Filtration
38. Gas Gangrene
39. Gastrointestinal Endoscopy
40. αGST
41. Gastric Residual Cutoff Value
42. πGST
43. π-Glutathione S-Transferase
44. Global End-Diastolic Volume (GEDV)
45. Gastro-intestinal Bleeding in ICU Patients
46. Geriatric Trauma
47. Gynecological Infections
48. Gastro-intestinal Hemorrhage
49. Gag Reflex
50. Group A Streptococcal Toxic Shock in Gynecology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.